Literature DB >> 31594833

The Use of Ultrasound as a Tool to Evaluate Pulmonary Disease in Cystic Fibrosis.

Andressa O Peixoto1,2,3, Fernando Al Marson1,2,4, Sérgio Sj Dertkigil5, Raquel P Dertkigil5, Tiago H Souza6,7, Andrea Ma Fraga6,3, Antônio F Ribeiro6, Adyléia Adc Toro6,2, José D Ribeiro6,2,3.   

Abstract

BACKGROUND: Lung ultrasound is an examination that allows the assessment of pulmonary involvement by analyzing artifacts. Our primary aim was to correlate our lung ultrasound findings with pulmonary function and the modified Bhalla score in patients with cystic fibrosis.
METHODS: Subjects with cystic fibrosis were evaluated based on the results of lung ultrasound, pulmonary function exams (ie, spirometry before and after the use of a bronchodilator and SpO2 ), and the modified Bhalla score. The partial correlation set by age between lung ultrasound, pulmonary function, and modified Bhalla score was carried out. Lung ultrasound was graded according to a new score, ranging from 0 to 36, with a higher score being associated with a greater degree of involvement. We performed Bland-Altman and linear regression analysis to identify bias between lung ultrasound and modified Bhalla score. Alpha = 0.05.
RESULTS: 18 subjects with cystic fibrosis were included. In partial correlation controlled by age, we observed significant ultrasound score values with weight (partial correlation = -0.579), body mass index (partial correlation = -0.609), SpO2 (partial correlation = -0.728), FVC% (pre-bronchodilator: partial correlation = -0.538; post-bronchodilator: partial correlation = -0.560), FEV1% (pre-bronchodilator: partial correlation = -0.536; post-bronchodilator: partial correlation = -0.546), and modified Bhalla score (partial correlation = 0.607). We did not identify bias between lung ultrasound and modified Bhalla score measured by z-score.
CONCLUSIONS: Lung ultrasound seems to be effective and corroborates with high-resolution computed tomography when evaluated by the modified Bhalla score. At the same time, lung ultrasound had significant correlation with pulmonary function and nutritional status.
Copyright © 2020 by Daedalus Enterprises.

Entities:  

Keywords:  CFTR; cystic fibrosis; diagnostic imaging; pulmonary disease; tomography; ultrasonic diagnosis; ultrasound

Mesh:

Year:  2019        PMID: 31594833     DOI: 10.4187/respcare.07038

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  4 in total

1.  Lung Ultrasound in Children with Cystic Fibrosis in Comparison with Chest Computed Tomography: A Feasibility Study.

Authors:  Ioana Mihaiela Ciuca; Liviu Laurentiu Pop; Mihaela Dediu; Emil Robert Stoicescu; Monica Steluta Marc; Aniko Maria Manea; Diana Luminita Manolescu
Journal:  Diagnostics (Basel)       Date:  2022-02-01

2.  Lung ultrasound assessment of response to antibiotic therapy in cystic fibrosis exacerbations: a study of two cases.

Authors:  Andressa Oliveira Peixoto; Fernando Augusto Lima Marson; Tiago Henrique Souza; Andrea de Melo Alexandre Fraga; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2019-11-25       Impact factor: 2.624

3.  Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation.

Authors:  Maryam Hassanzad; Arda Kiani; Atefeh Abedini; Hoseinali Ghaffaripour; Habib Emami; Niloufar Alizadeh; Ghazal Zoghi; Saeed Hashemi; Ali Akbar Velayati
Journal:  BMC Pulm Med       Date:  2021-11-08       Impact factor: 3.317

Review 4.  Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review.

Authors:  A O Peixoto; R M Costa; R Uzun; A M A Fraga; J D Ribeiro; F A L Marson
Journal:  Pulmonology       Date:  2021-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.